Skip to main content

BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1520354 Paris, I0

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$251,842,409
+$55,047,487 QoQ
Shares Held
1,494,259
+0.0% QoQ
Ownership
1.47%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#12
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $480,515,408 across 25 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (52.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
1,494,259 $251,842,409

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $251,842,409 1,494,259
2026-03-31 $196,794,922 1,493,813
2025-12-31 $197,980,779 1,395,902
2025-09-30 $133,084,871 948,033
2025-06-30 $129,749,282 1,032,296
2025-03-31 $138,814,721 1,255,106
2024-12-31 $128,956,736 944,738
2024-09-30 $94,476,712 819,968
2024-06-30 $107,777,711 782,870
2024-03-31 $108,983,417 790,193
2023-12-31 $94,945,333 720,593
2023-09-30 $76,312,124 678,330
2023-06-30 $61,957,174 657,022
2023-03-31 $62,012,837 612,654
2022-12-31 $65,854,079 551,357
2022-09-30 $56,663,671 533,506
2022-06-30 $43,653,201 447,817
2022-03-31 $33,654,093 358,977
2021-12-31 $31,733,660 372,592
2021-09-30 $37,572,742 391,750
2021-06-30 $38,241,115 392,942
2021-03-31 $31,456,485 323,460
2020-12-31 $24,732,079 258,029
2020-09-30 $25,376,239 263,896
2020-06-30 $27,005,066 221,353
2020-03-31 $20,415,760 235,884